Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole

PURPOSE: Proton pump inhibitors (PPIs) are the first-line therapy for gastroesophageal reflux disorder (GERD). Unlike conventional PPIs, non-enteric coated PPIs with antacid salt enable a faster acid suppression through the rapid absorption of the PPI. YPI-011 is a newly developed fixed-dose combina...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Sungyeun, Kwon, Jihoon, Lee, Mi-Hye, Yu, Kyung-Sang, Lee, SeungHwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939800/
https://www.ncbi.nlm.nih.gov/pubmed/36814893
http://dx.doi.org/10.2147/DDDT.S391716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939800/
https://www.ncbi.nlm.nih.gov/pubmed/36814893
http://dx.doi.org/10.2147/DDDT.S391716

Ejemplares similares